Intel
Intel Corp. (NASDAQ:INTC) shares skyrocketed nearly 10% in early trading on January 9, 2026, following a high-stakes meeting at the White House between CEO Lip-Bu Tan and President Donald Trump. The rally, which pushed the stock past a multi-year resistance level, comes as the administration signaled
Trump Tariffs
The U.S. Supreme Court on Friday, January 9, 2026, passed over its first scheduled opinion day of the year without issuing a ruling on the legality of the Trump administration’s sweeping global tariffs. The silence from the nation's highest court has extended a period of what
Jobs Report
The U.S. labor market kicked off 2026 with a report that offered a paradoxical blend of cooling demand and underlying strength. On Friday, the Bureau of Labor Statistics (BLS) revealed that while the economy added a modest 50,000 jobs in December—falling short of the 73,000 expected
S&P 500
The S&P 500 index surged to a historic intraday and closing high on Friday, January 9, 2026, as investors cheered a December employment report that appeared to hit the "Goldilocks" sweet spot for the U.S. economy. The benchmark index finished the session at approximately 6,
Olema Pharmaceuticals
Olema Pharmaceuticals (NASDAQ:OLMA) has become the latest focal point of biotech volatility and executive opportunism. Following a staggering 300% surge in its share price over the past year—fueled by a "rising tide" effect in the breast cancer treatment market—top insiders have begun offloading significant portions
Oklo
As of January 9, 2026, the intersection of artificial intelligence and carbon-free energy has reached a fever pitch, with Oklo Inc. (NYSE: OKLO) standing at the epicenter of this industrial revolution. The company’s stock has witnessed a staggering 36% surge in the first week of the new year,
Campbell Soup
In a move that has further dampened investor sentiment, a top executive at The Campbell’s Company (NYSE:CPB) has offloaded a significant portion of his holdings just as the consumer staples giant closes out one of its most challenging years in recent history. Charles A. Brawley III, the company’
Alibaba
As of January 9, 2026, the market for US-listed Chinese equities has entered a period of "volatile recovery," characterized by a tug-of-war between aggressive domestic stimulus from Beijing and a fragile geopolitical "trade truce" with Washington. Alibaba Group Holding Limited (NYSE: BABA), the
Lam Research
The first week of 2026 has marked a definitive turning point for the semiconductor industry, as a massive rally in equipment manufacturers signals the arrival of the "AI Infrastructure Supercycle." At the heart of this surge is Lam Research (NASDAQ: LRCX), which saw its stock price reach a
Goldman Sachs
As the Fourth Quarter 2025 earnings season kicks into high gear this January 2026, Goldman Sachs (NYSE: GS) has issued a stark warning to institutional and retail investors alike: the market is significantly underpricing the potential for explosive stock price movements. Strategists at the investment bank argue that the "
Novo Nordisk
As the first full week of 2026 unfolds, the pharmaceutical landscape is witnessing a seismic shift led by the Danish healthcare giant Novo Nordisk (NYSE: NVO). On January 5, 2026, the company officially launched the oral version of its blockbuster weight-loss drug, Wegovy, in the United States. This move
Mattel
The toy industry giant Mattel, Inc. (NASDAQ: MAT) found itself at the center of market volatility today, January 9, 2026, as the stock experienced a sharp reversal following a period of sustained momentum. After hitting a fresh 52-week high of $22.25 during yesterday’s session, the stock pivoted